2.13
Typ-I-Diabetes II: Pathophysiologie
Typ-1-Diabetes mellitus entsteht durch eine immunvermittelte Zerstörung der Bauchspeicheldrüsen-β-Zellen, was zu einem absoluten Insulinmangel führt.…
Bei Typ-1-Diabetes tragen genetische und Umweltfaktoren zu einer Autoimmunreaktion bei, bei der das Immunsystem die insulinproduzierenden Betazellen in der Bauchspeicheldrüse angreift.
Diese Betazellen leben in Clustern, die Langerhans-Inselchen genannt werden, und sind für die Insulinproduktion verantwortlich, ein Hormon, das es Glukose ermöglicht, zur Energie- oder Speicherung in die Zellen einzudringen.
Im Verlauf des Autoimmunprozesses werden T-Helfer-1-Zellen aktiviert und setzen entzündliche Zytokine wie Interferon-Gamma oder IFN-γ sowie Tumornekrosefaktor-Alpha oder TNF-α frei.
IFN-γ aktiviert insbesondere Makrophagen und stärkt die Antigenpräsentation. Diese Signale ermöglichen es zytotoxischen T-Zellen, Betazellen anzugreifen und zu zerstören, was zu Insulitis führt, die durch Entzündungen und Betazellschäden in den Langerhans-Inseln gekennzeichnet ist.
Im Laufe der Zeit zerstört die anhaltende Entzündung die Betazellen schrittweise, wodurch die Insulinproduktion drastisch reduziert oder vollständig eliminiert wird.
Ohne ausreichend Insulin kann Glukose nicht in die Zellen des Körpers gelangen und beginnt, sich im Blutkreislauf anzusammeln.
Dieser Blutzuckeranstieg führt zu einer Erkrankung, die als Hyperglykämie bekannt ist.
View the full transcript and gain access to JoVE Core videos
Q1: What role do the islets of Langerhans play in type 1 diabetes?
The islets of Langerhans are clusters of cells in the pancreas containing beta cells that produce insulin. In type 1 diabetes, these islets become inflamed through an autoimmune process called insulitis, where immune cells attack and destroy the insulin-producing beta cells, progressively reducing insulin production.
Q2: How do T helper 1 cells contribute to beta cell destruction in type 1 diabetes?
T helper 1 cells become activated against beta cell antigens and release pro-inflammatory cytokines, including interferon-gamma and tumor necrosis factor-alpha. These cytokines activate macrophages, enhance antigen presentation, and enable cytotoxic T cells to attack and destroy beta cells, perpetuating the autoimmune response.
Q3: What is the relationship between insulin deficiency and hyperglycemia in type 1 diabetes?
Insulin is required for glucose uptake into cells for energy or storage. Without sufficient insulin from destroyed beta cells, glucose cannot enter muscle and adipose tissue and accumulates in the bloodstream, causing hyperglycemia. This blood sugar buildup marks the clinical onset of type 1 diabetes.
Q4: How do genetic and environmental factors initiate the autoimmune response in type 1 diabetes?
Type 1 diabetes develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge. Genetic predisposition, including susceptibility alleles within HLA loci, influences autoimmune likelihood, while environmental triggers such as viral infections may precipitate or accelerate beta cell injury.
Q5: What is insulitis and how does it damage pancreatic beta cells?
Insulitis is an inflammatory infiltration of the islets of Langerhans characterized by T cells, macrophages, and other immune effectors. Chronic exposure to cytotoxic mediators from these immune cells leads to apoptosis and progressive depletion of beta cell mass, eventually eliminating insulin production capacity.
Q6: How does interferon-gamma amplify the immune attack on beta cells?
Interferon-gamma, released by activated T helper 1 cells, plays a central role in amplifying the immune response by promoting macrophage activation and enhancing antigen presentation. These enhanced signals allow cytotoxic T cells to more effectively recognize and attack beta cells, intensifying the autoimmune destruction.
Q7: What distinguishes type 1 diabetes from other forms of diabetes mellitus?
Type 1 diabetes results from immune-mediated destruction of pancreatic beta cells, causing absolute insulin deficiency. This contrasts with other diabetes types where insulin production may be preserved but ineffective. Understanding type 1 diabetes pathophysiology helps explain its acute onset and distinct clinical presentation compared to other forms.